Search Results for "European Heart Journal Impact"
Original Source: The European Journal of Heart Failure in 2010: current impact factor, time-to-first decision, and number of submissions.
Matching Channels
Matching News
World Heart Day: New European statistics released on heart disease and stroke
(European Society of Cardiology) New figures released to mark World Heart Day show a significant improvement in Europe's heart health. The European Society of Cardiology and the European Heart Networ...
GENCARO CARDIOVASCULAR EFFECT ON PATIENTS WITH ATRIAL FIBRILLATION
ARCA biopharma, Inc. (Broomfield), a biopharmaceutical company developing genetically-targeted therapies for atrial fibrillation and other cardiovascular diseases, announced that the paper "Effect of...
The Role of the Kidney in Heart Failure
Learn how the evaluation of renal function in patients with heart failure can add to prognostic assessment. European Heart Journal
Heart Rhythm Society, ECAS and EHRA develop 2012 expert consensus statement on AF ablation
The 2012 expert consensus statement on catheter and surgical ablation of atrial fibrillation was developed by the Heart Rhythm Society (HRS), the European Heart Rhythm Association (EHRA), a registered...
Effects of Celecoxib on Restenosis After PCI
For angina patients receiving drug-eluting stents, does celecoxib have a big enough impact on late loss outcomes to offset the risk? European Heart Journal
For patients with heart failure, serum sodium may have a meaningful message. . . European Journal of Heart Failure
Impact of Universal Definition of MI on Mortality
What has the universal definition of MI done to change the frequency of this diagnosis, and how has it altered outcomes? European Heart Journal
Cardiovascular Effects of Chocolate in Heart Failure
How much chocolate should you prescribe for patients with heart failure? European Heart Journal
Matching PubMed Articles
Exercise training in Chagas' cardiomyopathy: trials are welcome for this neglected heart disease.
Quantifying the amount of congestion in heart failure.
Possible benefit of cardiac resynchronization therapy with ejection fraction >35%: reply.